178 related articles for article (PubMed ID: 34253872)
1. Proton pump inhibitors and survival in patients with colorectal cancer: a Swedish population-based cohort study.
Wang X; Liu Q; Halfdanarson ÓÖ; Zoega H; Sadr-Azodi O; Engstrand L; Fall K; Brusselaers N
Br J Cancer; 2021 Sep; 125(6):893-900. PubMed ID: 34253872
[TBL] [Abstract][Full Text] [Related]
2. Maintenance Proton Pump Inhibitor Use Associated with Increased All-Cause and Cause-Specific Mortality in Sweden.
Ngwenya S; Simin J; Brusselaers N
Dig Dis Sci; 2023 Jun; 68(6):2252-2263. PubMed ID: 36629968
[TBL] [Abstract][Full Text] [Related]
3. Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in Sweden.
Brusselaers N; Wahlin K; Engstrand L; Lagergren J
BMJ Open; 2017 Oct; 7(10):e017739. PubMed ID: 29084798
[TBL] [Abstract][Full Text] [Related]
4. Proton pump inhibitor use increases mortality and hepatic decompensation in liver cirrhosis.
De Roza MA; Kai L; Kam JW; Chan YH; Kwek A; Ang TL; Hsiang JC
World J Gastroenterol; 2019 Sep; 25(33):4933-4944. PubMed ID: 31543684
[TBL] [Abstract][Full Text] [Related]
5. Proton pump inhibitor use by aspirin-treated coronary artery disease patients is not associated with increased risk of cardiovascular events.
Fortuna LA; Pawloski PA; Parker ED; Trower NK; Kottke TE
Eur Heart J Cardiovasc Pharmacother; 2016 Jan; 2(1):13-9. PubMed ID: 27533057
[TBL] [Abstract][Full Text] [Related]
6. Colorectal cancer in Crohn's disease: a Scandinavian population-based cohort study.
Olén O; Erichsen R; Sachs MC; Pedersen L; Halfvarson J; Askling J; Ekbom A; Sørensen HT; Ludvigsson JF
Lancet Gastroenterol Hepatol; 2020 May; 5(5):475-484. PubMed ID: 32066530
[TBL] [Abstract][Full Text] [Related]
7. Use of proton pump inhibitors and mortality among Icelandic patients with prostate cancer.
Hálfdánarson ÓÖ; Pottegård A; Lund SH; Ogmundsdottir MH; Ogmundsdottir HM; Zoega H
Basic Clin Pharmacol Toxicol; 2020 Jun; 126(6):484-491. PubMed ID: 31872571
[TBL] [Abstract][Full Text] [Related]
8. Proton Pump Inhibitors and Survival in Patients With Colorectal Cancer Receiving Fluoropyrimidine-Based Chemotherapy.
Kichenadasse G; Miners JO; Mangoni AA; Karapetis CS; Hopkins AM; Sorich MJ
J Natl Compr Canc Netw; 2021 May; 19(9):1037-1044. PubMed ID: 33951613
[TBL] [Abstract][Full Text] [Related]
9. Use of hormone replacement therapy improves the prognosis in patients with colorectal cancer: A population-based study in Sweden.
Ji J; Sundquist J; Sundquist K
Int J Cancer; 2018 May; 142(10):2003-2010. PubMed ID: 29270993
[TBL] [Abstract][Full Text] [Related]
10. Preadmission use of antidepressants and risk of complications and death after colorectal cancer surgery: a nationwide population-based cohort study.
Lycke KD; Christiansen CF; Lund JL; Iversen LH; Nørgaard M
Colorectal Dis; 2019 Jun; 21(6):651-662. PubMed ID: 30740875
[TBL] [Abstract][Full Text] [Related]
11. Do proton pump inhibitors affect the effectiveness of chemotherapy in colorectal cancer patients? A systematic review with meta-analysis.
Lin WY; Wang SS; Kang YN; Porpiglia AS; Chang Y; Huang CH; Bhimani R; Abdul-Lattif E; Azmat M; Wang TH; Lin YS; Chang YC; Chi KY
Front Pharmacol; 2022; 13():1048980. PubMed ID: 36578549
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort study.
Olén O; Erichsen R; Sachs MC; Pedersen L; Halfvarson J; Askling J; Ekbom A; Sørensen HT; Ludvigsson JF
Lancet; 2020 Jan; 395(10218):123-131. PubMed ID: 31929014
[TBL] [Abstract][Full Text] [Related]
13. Proton pump inhibitor use and cancer mortality.
Tvingsholm SA; Dehlendorff C; Østerlind K; Friis S; Jäättelä M
Int J Cancer; 2018 Sep; 143(6):1315-1326. PubMed ID: 29658114
[TBL] [Abstract][Full Text] [Related]
14. Emerging hazard effects of proton pump inhibitor on the risk of colorectal cancer in low-risk populations: A Korean nationwide prospective cohort study.
Hwang IC; Chang J; Park SM
PLoS One; 2017; 12(12):e0189114. PubMed ID: 29216279
[TBL] [Abstract][Full Text] [Related]
15. Increased mortality in patients with hematologic malignancies treated with proton pump inhibitors: a nationwide cohort study.
Vilmar A; Dehlendorff C; Friis S; Jäättelä M; Tvingsholm S; Frederiksen H
Leuk Lymphoma; 2023; 64(8):1451-1457. PubMed ID: 37293759
[TBL] [Abstract][Full Text] [Related]
16. Proton pump inhibitors and risk of all-cause and cause-specific mortality: A cohort study.
Brown JP; Tazare JR; Williamson E; Mansfield KE; Evans SJ; Tomlinson LA; Bhaskaran K; Smeeth L; Wing K; Douglas IJ
Br J Clin Pharmacol; 2021 Aug; 87(8):3150-3161. PubMed ID: 33393677
[TBL] [Abstract][Full Text] [Related]
17. Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.
Lazarus B; Chen Y; Wilson FP; Sang Y; Chang AR; Coresh J; Grams ME
JAMA Intern Med; 2016 Feb; 176(2):238-46. PubMed ID: 26752337
[TBL] [Abstract][Full Text] [Related]
18. Use of oral proton pump inhibitors is not associated with harm in patients with chronic heart failure in an ambulatory setting.
Oudit GY; Bakal JA; McAlister FA; Ezekowitz JA
Eur J Heart Fail; 2011 Nov; 13(11):1211-5. PubMed ID: 21831912
[TBL] [Abstract][Full Text] [Related]
19. Risk of death among users of Proton Pump Inhibitors: a longitudinal observational cohort study of United States veterans.
Xie Y; Bowe B; Li T; Xian H; Yan Y; Al-Aly Z
BMJ Open; 2017 Jul; 7(6):e015735. PubMed ID: 28676480
[TBL] [Abstract][Full Text] [Related]
20. Lack of Association Between Proton Pump Inhibitor Use and Cognitive Decline.
Wod M; Hallas J; Andersen K; García Rodríguez LA; Christensen K; Gaist D
Clin Gastroenterol Hepatol; 2018 May; 16(5):681-689. PubMed ID: 29391266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]